Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non-small cell lung cancer.
Lengel HB, Zheng J, Tan KS, Liu CC, Park BJ, Rocco G, Adusumilli PS, Molena D, Yu HA, Riely GJ, Bains MS, Rusch VW, Kris MG, Chaft JE, Li BT, Isbell JM, Jones DR. Lengel HB, et al. Among authors: chaft je. J Thorac Cardiovasc Surg. 2023 May;165(5):1682-1693.e3. doi: 10.1016/j.jtcvs.2022.10.056. Epub 2022 Nov 17. J Thorac Cardiovasc Surg. 2023. PMID: 36528430 Free PMC article.
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
Forde PM, Chaft JE, Pardoll DM. Forde PM, et al. Among authors: chaft je. N Engl J Med. 2018 Aug 30;379(9):e14. doi: 10.1056/NEJMc1808251. N Engl J Med. 2018. PMID: 30157404 No abstract available.
Genetics of vascular anomalies: an update.
Chaft JE, Steckman DA, Blei F. Chaft JE, et al. Lymphat Res Biol. 2003;1(4):283-9. doi: 10.1089/153968503322758085. Lymphat Res Biol. 2003. PMID: 15624556 Review.
Molecular characteristics predict clinical outcomes: prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene.
Rizvi NA, Rusch V, Pao W, Chaft JE, Ladanyi M, Miller VA, Krug LM, Azzoli CG, Bains M, Downey R, Flores R, Park B, Singh B, Zakowski M, Heelan RT, Shen R, Kris MG. Rizvi NA, et al. Among authors: chaft je. Clin Cancer Res. 2011 May 15;17(10):3500-6. doi: 10.1158/1078-0432.CCR-10-2102. Epub 2011 May 10. Clin Cancer Res. 2011. PMID: 21558399 Free PMC article. Clinical Trial.
Incorporation of crizotinib into the NCCN guidelines.
Riely GJ, Chaft JE, Ladanyi M, Kris MG. Riely GJ, et al. Among authors: chaft je. J Natl Compr Canc Netw. 2011 Dec;9(12):1328-30. doi: 10.6004/jnccn.2011.0113. J Natl Compr Canc Netw. 2011. PMID: 22157552 No abstract available.
146 results